Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concentration Monitoring of Safety for Reduning TCM Injection
ChiCTR-OCS-12002485Phase 4Recruiting
- Sponsor
- Tianjin TCM Institute of Clinical Evaluation
- Start
- Aug 2012
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Reduning in Infectious disease, sponsored by Tianjin TCM Institute of Clinical Evaluation. Primary endpoint: Safety-related concentration monitoring of Reduning injection. Started Aug 2012; status: recruiting.
02
Drugs
Reduning
03
Conditions
Infectious disease
Beyond the preview
Go deeper on ChiCTR-OCS-12002485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OCS-12002485.